Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2165 (LINC02165) is a long non-coding RNA (lncRNA) that does not encode a protein[1][3]. LINC02165 is annotated in human gene databases (for example, NCBI Gene 101927629, Ensembl ENSG00000261014) but its biological function, disease involvement, or utility as a diagnostic or therapeutic target are currently uncharacterized. In general, long intergenic non-coding RNAs (lincRNAs) can play regulatory roles in gene expression, chromatin architecture, or RNA processing, but there is no evidence from current sources that LINC02165 specifically has any established function, clinical biomarker value, or drug interaction[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2165 (LINC02165).